🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
BCY
$BCYC
🔒 US EquitiesBicycle Therapeutics plc
AVG HISTORICAL GAP
+0.46%
MAX GAP RECORD
+3.53%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $BCYC
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$BCYC
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 29, 2026 Earnings Release 2026-10-29 (BEFORE OPEN (08:00)) |
+1.03%
|
| Jul 30, 2026 Earnings Release 2026-07-30 (BEFORE OPEN) |
+0.00%
|
| Apr 30, 2026 Earnings Release 2026-04-30 (AFTER CLOSE) |
-0.85%
|
| Oct 30, 2025 Earnings Release 2025-10-30 (BEFORE OPEN) |
+0.00%
|
| Aug 08, 2025 Earnings Release 2025-08-08 (BEFORE OPEN) |
+1.21%
|
| Apr 30, 2025 Earnings Release 2025-04-30 (BEFORE OPEN) |
+3.53%
|
| Feb 25, 2025 Earnings Release 2025-02-25 (BEFORE OPEN) |
+0.00%
|
| Oct 31, 2024 Earnings Release 2024-10-31 (BEFORE OPEN) |
-3.04%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.0%
Bullish Gaps (6)
Bearish Gaps (4)
Neutral / Flat (1)
📖 Intelligence Summary
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company's products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase II clinical trials for the treatment…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗